SCULLY WILLIAM P purchased $1.4M of PRTA (indirect holdings)
SCULLY WILLIAM P purchased 162,000 indirectly-held shares of PROTHENA CORP PUBLIC LTD CO (PRTA) at $8.68 ($1.41M total) on 2026-09-29.
How this was made
The 30-second read
Why it matters
The filing adds a new data point on insider ownership, which was not previously public.
Market read
A fresh insider purchase by a major shareholder provides a modest bullish cue for PRTA.
What to watch
Potential upcoming clinical data releases that may have prompted the insider to increase exposure.
Background
SEC Form 4 disclosures are primary sources for insider transactions and are used by traders to gauge insider sentiment.
Ticker impact
Form 4 filing shows 10% owner William Scully bought 162,000 shares for $1.4 M, increasing his stake to 214,000 shares.
likely upward pressure as the market prices in the insider buying
The purchase size is modest but the buyer holds a 10% stake, making the signal material for a micro‑cap.
Market effects
Minimal impact on the broader biotech sector; only relevant to PRTA investors.
None
Low
Counterpoint
The purchase could be a routine portfolio rebalancing rather than a bullish signal.
Key entities
- CompanyProthena Corp Public Ltd Co
Biotech firm listed on NASDAQ under PRTA.
- InsiderWilliam Scully
10% owner who filed the purchase.
